The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
暂无分享,去创建一个
J. McMurray | H. Mischak | A. McConnachie | P. Welsh | A. Jasilek | C. Delles | A. Latosinska | R. Campbell | C. Jackson | E. Nkuipou-Kenfack | Jane A Cannon
[1] Miriam J. Johnson,et al. Which patients with heart failure should receive specialist palliative care? , 2018, European journal of heart failure.
[2] J. Butler,et al. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives. , 2018, Journal of the American College of Cardiology.
[3] Kaleab Z. Abebe,et al. Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome , 2017, JAMA cardiology.
[4] Harald Mischak,et al. Left ventricular diastolic function in relation to the urinary proteome: A proof-of-concept study in a general population , 2014, International journal of cardiology.
[5] J. Ioannidis,et al. Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience. , 2013, Clinical biochemistry.
[6] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[7] J. Staessen,et al. Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction. , 2012, European heart journal.
[8] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[9] J. McMurray,et al. Profile of microvolt T‐wave alternans testing in 1003 patients hospitalized with heart failure , 2012, European journal of heart failure.
[10] Robert N. Doughty,et al. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. , 2011, European heart journal.
[11] D. Atar,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡ , 2008, European journal of heart failure.
[12] F. Triposkiadis,et al. Cognitive Impairment in Heart Failure , 2006, Dimensions of critical care nursing : DCCN.
[13] H. Frierson,et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. , 2006, The Lancet. Oncology.
[14] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] C. Camargo,et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. , 2005, The American journal of cardiology.
[16] Walter Kolch,et al. Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches , 2005, Electrophoresis.
[17] Alan S Maisel,et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.
[18] J. Pell,et al. Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.
[19] P. Ponikowski,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016 .
[20] Miriam J. Johnson,et al. Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. , 2015, ESC heart failure.